CR8977A - HIGH DOSES OF IBANDRONATE FORMULATIONS - Google Patents

HIGH DOSES OF IBANDRONATE FORMULATIONS

Info

Publication number
CR8977A
CR8977A CR8977A CR8977A CR8977A CR 8977 A CR8977 A CR 8977A CR 8977 A CR8977 A CR 8977A CR 8977 A CR8977 A CR 8977A CR 8977 A CR8977 A CR 8977A
Authority
CR
Costa Rica
Prior art keywords
formulations
high doses
ibandronate
preparation
doses
Prior art date
Application number
CR8977A
Other languages
Spanish (es)
Inventor
Hans G Kaestle
Bernard Meyer
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44839359&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR8977(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Priority to CR8977A priority Critical patent/CR8977A/en
Publication of CR8977A publication Critical patent/CR8977A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invencion se refiere a dosis altas de formulacion oral de bisfosfonatos y a un proceso para la preparacion de tales formulaciones.The invention relates to high doses of oral bisphosphonate formulation and a process for the preparation of such formulations.

CR8977A 2007-03-06 2007-03-06 HIGH DOSES OF IBANDRONATE FORMULATIONS CR8977A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CR8977A CR8977A (en) 2007-03-06 2007-03-06 HIGH DOSES OF IBANDRONATE FORMULATIONS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CR8977A CR8977A (en) 2007-03-06 2007-03-06 HIGH DOSES OF IBANDRONATE FORMULATIONS

Publications (1)

Publication Number Publication Date
CR8977A true CR8977A (en) 2007-11-23

Family

ID=44839359

Family Applications (1)

Application Number Title Priority Date Filing Date
CR8977A CR8977A (en) 2007-03-06 2007-03-06 HIGH DOSES OF IBANDRONATE FORMULATIONS

Country Status (1)

Country Link
CR (1) CR8977A (en)

Similar Documents

Publication Publication Date Title
CR7549A (en) HIGH DOSES OF IBANDRONATE FORMULATIONS
MY159358A (en) Compositions comprising sphingosine 1 phosphate (s1p) receptor modulators
ECSP10010489A (en) New formulations, tablets comprising such formulations, their use and procedure for their preparation
CR11709A (en) SOLID PREPARATION OF ORAL DISINTEGRATION
MX336497B (en) Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as c5a receptor modulators.
MX339408B (en) Alcohol resistant enteric pharmaceutical compositions.
UY32156A (en) SUBSTITUTED DERIVATIVES OF THE N2 - [1- (5 - FLUOROPIRIMIDIN -2-IL) ETIL] - N4 - (1-METHYL - 1H-IMIDAZOL - 4 - IL)) - PYRIMIDINE - 2,4 - DIAMINES AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS , PREPARATION PROCESS, COMPOSITIONS CONTAINING THEM AND APPLICATIONS.
MY187718A (en) Pharmaceutical formulations
CR11285A (en) PHARMACEUTICAL COMPOSITION CONTAINING AN ANTIGONIST OF THE CALCIUM CHANNEL OF TYPE DIHIPROPIRIDINE AND METHOD FOR THE PREPARATION OF THE SAME
MX349145B (en) Oral formulations and lipophilic salts of methylnaltrexone.
TN2011000585A1 (en) Lxr modulators
MX2011007267A (en) Pharmaceutical compositions comprising 2-oxo-1-pyrrolidine derivatives.
MY163746A (en) Formulations comprising 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol
MX2011007451A (en) Pharmaceutical compositions comprising 2-oxo-1-pyrrolidine derivatives.
WO2012074830A3 (en) Modified release tranexamic acid formulation
UY31128A1 (en) FORMULATION OF NEVIRAPINE OF PROLONGED RELEASE
AR076181A1 (en) COMPOUNDS DERIVED FROM MENTOL AND USE OF THE SAME AS ORAL AND SYSTEMIC ACTIVE AGENTS. METHOD. COMPOSITION.
UY33348A (en) FUROPIRIDINE COMPOUNDS AND USES OF THE SAME
PA8717801A1 (en) PHARMACEUTICAL FORMULATIONS OF A CRYSTALLINE FORM OF MONOHIDRATE OF 2- (3-FLUOR-4-HYDROXYPHENYL) -7-VINYL-1,3-BENZOXAZOL-5-OL
PH12015501251A1 (en) Compositions and methods for treating dental caries
CR8977A (en) HIGH DOSES OF IBANDRONATE FORMULATIONS
MX2012014071A (en) Stable pharmaceutical composition for treating osteoporosis.
ECSP11011138A (en) PRE-COMPACTED QUICK DISINTEGRATION FORMULATIONS OF COMPOUNDS WITH LOW ORAL BIOD AVAILABILITY
CR11210A (en) STABLE FORMULATIONS OF TIADIAZOL DERIVATIVE
PH12012000220A1 (en) Solid pharmaceutical composition for buccal administration of agomelatine